Efficacy and Safety Results of the Afatinib Expanded Access Program
Crossref DOI link: https://doi.org/10.1007/s40487-017-0043-5
Published Online: 2017-04-10
Published Print: 2017-06
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Kim, Edward S.
Halmos, Balazs
Kohut, Ingrid F.
Patel, Taral
Rostorfer, Regan D.
Spira, Alexander I.
Cseh, Agnieszka
McKay, John
Wallenstein, Gudrun
Mileham, Kathryn F.
Funding for this research was provided by:
Boehringer Ingelheim